PlainRecalls
FDA Drug Critical Class I Terminated

5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.

Reported: March 26, 2014 Initiated: November 21, 2013 #D-1162-2014

Product Description

5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.

Reason for Recall

Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag

Details

Recalling Firm
Baxter Healthcare Corp.
Units Affected
105,216 containers
Distribution
Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.. Recalled by Baxter Healthcare Corp.. Units affected: 105,216 containers.
Why was this product recalled?
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2014. Severity: Critical. Recall number: D-1162-2014.